Login

Traffic Data on SKY TG24 Business | Pasqualino Monti - CEO of ENAV 00:10:00

Share On Facebook Share On Twitter

Pasqualino Monti is Chief Executive Officer of ENAV since 28 April 2023.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:00:00
Overview of the competitive advantages of Genkyotex’s products - Mr Elias Papatheodorou, CEO, GenKyoTex
00:10:00
Interview with Raymond Racaza of Xurpas | Jonathan Gerard A. Gurango, CEO, Xurpas IncX:PHS
00:10:00
Standing Out to Clients: Insights from Morgan Stanley's CMO and Facebook's VP of Global Marketing Solutions
00:10:00
Daniel Needham on Aligning Investment Strategies with Client Goals
00:10:00
Navitas Semiconductor CEO Gene Sheridan provides insights on Q2 results, business challenges, and future prospects on 'Power Lunch'.|Gene Sheridan, CEO of Navitas Semiconductor
00:10:00
Wealth Minerals: Advancing Lithium Projects in Chile Amid Regulatory Challenges
00:10:00
Helix Resources Explores Cobar's Untapped Potential: Multi-Project Copper and Gold Ventures|Dr. Kylie Prendergast,Managing Director, Helix Resources Ltd.
00:10:00
Empowering Women in Finance: Sallie Krawcheck's Journey
00:10:00
Artemis Resources: Advancing Carlo Castle Gold-Copper-Cobalt Project with Radio Hill Processing Plant
00:10:00
Empowering Communities Through Financial Health and Workforce Development
00:10:00
ROCA Industry’s Ionuț Bindea Discusses Market Dynamics and Growth Potential | Ionuț Bindea, CEO, ROCA Industry Holdingrock1 SA.
00:10:00
Sustainable Bonds: ESG Strategies in Fixed Income | Natasha Page - Director of Fixed Income ESG, Janus Henderson Investors

© 2026 Nehu